Jan 10, 2022 / 07:15PM GMT
Eric William Joseph - JPMorgan Chase & Co, Research Division - VP & Senior Analyst
Okay. Good afternoon, and welcome again to the 40th Annual JPMorgan Healthcare Conference. I'm Eric Joseph, senior biotech analyst at the firm. Our next presenting company is Beam Therapeutics, and it's my pleasure to welcome CEO, John Evans, to talk to us about the company. There is a Q&A session after the presentation. (Operator Instructions) And I'll work them in where appropriate.
So with that, John, thanks again for sharing some of your time with us this afternoon.
John M. Evans - Beam Therapeutics Inc. - CEO & Director
Great. Thank you, Eric. And it's really great to be here, albeit virtually, but really excited to tell you all a little bit about Beam and some of the things we've been up to.
So on, I guess, Slide 2, probably just remind you that I may make forward-looking statements today.
Okay. So on Slide 3. So Beam, for those of you who are getting to know us, our vision is to provide lifelong cures for patients suffering from
Beam Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Feb 06, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers